1. Lansky AJ, Stone GW (2010) Periprocedural myocardial infarction: prevalence, prognosis, and prevention. Circ Cardiovasc Interv 3(6):602–610
2. Writing Group M, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ et al (2016) Heart disease and stroke Statistics-2016 update: a report from the American Heart Association. Circulation. 133(4):e38–e360
3. Visternichan O, Jalali SF, Taizhanova D, Muravlyova L, Igimbayeva G (2019) Dynamic changes in purine catabolism in patients with acute coronary syndrome that underwent percutaneous coronary intervention. Caspian J Intern Med 10(1):86–91
4. Farhat N, Haddad N, Crispo J, Birkett N, McNair D, Momoli F, Wen SW, Mattison DR, Krewski D (2019) Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016. Eur J Clin Pharmacol 75(2):227–235
5. Davidson SM, Ferdinandy P, Andreadou I, Bøtker HE, Heusch G, Ibáñez B, Ovize M, Schulz R, Yellon DM, Hausenloy DJ, Garcia-Dorado D, CARDIOPROTECTION COST Action (CA16225) (2019) Multitarget strategies to reduce myocardial ischemia/reperfusion injury: JACC review topic of the week. J Am Coll Cardiol 73(1):89–99